{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17886224", "DateCompleted": {"Year": "2008", "Month": "06", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0951-418X", "JournalIssue": {"Volume": "22", "Issue": "2", "PubDate": {"Year": "2008", "Month": "Feb"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Antiviral effects of Glycyrrhiza species.", "Pagination": {"StartPage": "141", "EndPage": "148", "MedlinePgn": "141-8"}, "Abstract": {"AbstractText": ["Historical sources for the use of Glycyrrhiza species include ancient manuscripts from China, India and Greece. They all mention its use for symptoms of viral respiratory tract infections and hepatitis. Randomized controlled trials confirmed that the Glycyrrhiza glabra derived compound glycyrrhizin and its derivatives reduced hepatocellular damage in chronic hepatitis B and C. In hepatitis C virus-induced cirrhosis the risk of hepatocellular carcinoma was reduced. Animal studies demonstrated a reduction of mortality and viral activity in herpes simplex virus encephalitis and influenza A virus pneumonia. In vitro studies revealed antiviral activity against HIV-1, SARS related coronavirus, respiratory syncytial virus, arboviruses, vaccinia virus and vesicular stomatitis virus. Mechanisms for antiviral activity of Glycyrrhiza spp. include reduced transport to the membrane and sialylation of hepatitis B virus surface antigen, reduction of membrane fluidity leading to inhibition of fusion of the viral membrane of HIV-1 with the cell, induction of interferon gamma in T-cells, inhibition of phosphorylating enzymes in vesicular stomatitis virus infection and reduction of viral latency. Future research needs to explore the potency of compounds derived from licorice in prevention and treatment of influenza A virus pneumonia and as an adjuvant treatment in patients infected with HIV resistant to antiretroviral drugs."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical and Surgical Sciences-Endocrinology, University of Padua, Padova, Italy."}], "Identifier": [], "LastName": "Fiore", "ForeName": "Cristina", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Eisenhut", "ForeName": "Michael", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Krausse", "ForeName": "Rea", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ragazzi", "ForeName": "Eugenio", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pellati", "ForeName": "Donatella", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Armanini", "ForeName": "Decio", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bielenberg", "ForeName": "Jens", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "6FO62043WK", "NameOfSubstance": "Glycyrrhizic Acid"}, {"RegistryNumber": "P540XA09DR", "NameOfSubstance": "Glycyrrhetinic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Glycyrrhetinic Acid"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Glycyrrhizic Acid"}, {"QualifierName": ["drug effects"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abe N, Ebina T, Ishida N. 1982. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Biol 26: 535\u2013539.", "ArticleIdList": ["6290851"]}, {"Citation": "Acharya SK, Dasarathy S, Tandon A, Joshi YK, Tandon BN. 1993. A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure. Indian J Med Res 98: 69\u201374.", "ArticleIdList": ["8344734"]}, {"Citation": "Arase Y, Ikeda K, Murashima N et al. 1997. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79: 1494\u20131500.", "ArticleIdList": ["9118029"]}, {"Citation": "Armanini D, Fiore C, Bielenberg J, Ragazzi E. 2005. Licorice (Glycyrrhiza glabra) In Encyclopedia of Dietary Supplements, Coates P. (ed.). Marcel Dekker Inc.: New York, 391\u2013399."}, {"Citation": "Armanini D, Fiore C, Matterello MJ, Bielenberg J, Palermo M. 2002. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabet 110: 257\u2013261.", "ArticleIdList": ["12373628"]}, {"Citation": "Baba M, De Cleroq S, Nakashima H, Yamamoto N. 1988. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res 10: 289\u2013298.", "ArticleIdList": ["3250333"]}, {"Citation": "Baba M, Shigeta S. 1987. Antiviral activity of glycyrrhizin against varicella\u2010zoster virus in vitro . Antiviral Res 7: 99\u2013107.", "ArticleIdList": ["3034150"]}, {"Citation": "Badam L. 1997. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J Commun Dis 29: 91\u201399.", "ArticleIdList": ["9282507"]}, {"Citation": "Baltina LA. 2003. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr Med Chem 10: 155\u2013171.", "ArticleIdList": ["12570715"]}, {"Citation": "Barnes J, Anderson LAA, Phillipson JD. 2002. Herbal Medicines 2nd edn. Pharmaceutical Press: London, 325\u2013329."}, {"Citation": "Blumenthal M, Goldberg A, Brinckmann J, Foster S. 2000. Herbal Medicine. Expanded Commission E Monographs, American Botanical Council: Austin TX, 233\u2013239."}, {"Citation": "Chen F, Chan KH, Jiang Y et al. 2004. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 31: 69\u201375.", "ArticleIdList": ["PMC7128415", "15288617"]}, {"Citation": "Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. 2003. Glycyrrhizin, an active component of liquorice root, and replication of SARS\u2010associated coronavirus. Lancet 361: 2045\u20132046.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Cohen JI. 2005. Licking latency with licorice. J Clin Invest 115: 591\u2013593.", "ArticleIdList": ["PMC1052015", "15765143"]}, {"Citation": "Crance JM, Biziagos E, Passagot J, van Cuyck\u2010Gandre H, Deloince R. 1990. Inhibition of hepatitis A virus replication in vitro by antiviral compounds. J Med Virol 31: 155\u2013160.", "ArticleIdList": ["2167349"]}, {"Citation": "Crance JM, Scaramozzino N, Jouan A, Garin D. 2003. Interferon, ribavirin, 6\u2010azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 58: 73\u201379.", "ArticleIdList": ["12719009"]}, {"Citation": "Curreli F, Friedman\u2010Kein AE, Flore O. 2005. Glycyrrhizic acid alters Kaposi sarcoma\u2010associated herpesvirus latency, triggering p53\u2010mediated apoptosis in transformed B lymphocytes. J Clin Invest 115: 642\u2013652.", "ArticleIdList": ["PMC1051998", "15765147"]}, {"Citation": "De Clercq E. 2000. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev 20: 323\u2013349.", "ArticleIdList": ["10934347"]}, {"Citation": "Eisenburg J. 1992. Treatment of chronic hepatitis B. Part 2: Effect of glycyrrhizic acid on the course of illness. Fortschritt Med 110: 395\u2013398.", "ArticleIdList": ["1516877"]}, {"Citation": "Evans WC. 2002. Trease and Evans Pharmacognosy, 15th edn. Saunders: Edinburgh\u2010London\u2010New York, 299\u2013302."}, {"Citation": "Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D. 2005. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol 99: 317\u2013324.", "ArticleIdList": ["PMC7125727", "15978760"]}, {"Citation": "Fujii T, Nakamura T, Iwamoto A. 2004. Current concepts in SARS treatment. J Infect Chemother 10: 1\u20137.", "ArticleIdList": ["PMC7088022", "14991510"]}, {"Citation": "Gotoh Y, Tada K, Yamada M et al. 1987. Administration of glycyrrhizin to patients with human immunodeficiency virus infection. Igaku no Ayumi 140: 619\u2013620."}, {"Citation": "Harada S. 2005. The broad anti\u2010viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV\u20101 envelope. Biochem J 392: 191\u2013199.", "ArticleIdList": ["PMC1317678", "16053446"]}, {"Citation": "Harada S, Maekawa T, Haneda E, Morikawa Y, Nagata N, Ohtsuki K. 1998. Biochemical characterisation of recombinant HIV\u20101 reverse transcriptase (rRT) as a glycyrrhizin\u2010binding protein and the CK\u2010II\u2010mediated stimulation of rRT activity potently inhibited by glycyrrhetenic acid derivate. Biol Pharm Bull 21: 1282\u20131284.", "ArticleIdList": ["9881639"]}, {"Citation": "Hoever G, Baltina L, Michaelis M et al. 2005. Antiviral activity of glycyrrhizic acid derivatives against SARS\u2010coronavirus. J Med Chem 48: 1256\u20131259.", "ArticleIdList": ["15715493"]}, {"Citation": "Ikeda K, Arase Y, Kobayashi M et al. 2006. A long\u2010term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon\u2010resistant active chronic hepatitis C: A cohort study of 1249 patients. Dig Dis Sci 51: 603\u2013609.", "ArticleIdList": ["16614974"]}, {"Citation": "Isbrucker RA, Burdock GA. 2006. Risk and safety assessment on the consumption of licorice root (Gycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Reg Toxicol Pharmacol 46: 167\u2013192.", "ArticleIdList": ["16884839"]}, {"Citation": "Ito M, Nakashima H, Baba M et al. 1987. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus. Antivir Res 7: 127\u2013137.", "ArticleIdList": ["3475037"]}, {"Citation": "Jeong HG, You HJ, Park SJ et al. 2002. Hepatoprotective effects of 18beta\u2010glycyrrhetinic acid on carbon tetrachloride\u2010induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol Res 46: 221\u2013227.", "ArticleIdList": ["12220964"]}, {"Citation": "Kiso Y, Tohkin M, Hikino H, Hattori M, Sakamoto T, Namba T. 1984. Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation. Planta Med 50: 298\u2013302.", "ArticleIdList": ["6505079"]}, {"Citation": "Ko HC, Wei BL, Chiou WF. 2006. The effect of medicinal plants used in Chinese folk medicine on RANTES secretion by virus\u2010infected human epithelial cells. J Ethnopharmacol 107: 205\u2013210.", "ArticleIdList": ["16621378"]}, {"Citation": "Kumada H. 2002. Long\u2010term treatment of chronic hepatitis C with glycyrrhizin [Stronger Neo\u2010Minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 62 (suppl 1): 94\u2013100.", "ArticleIdList": ["11868794"]}, {"Citation": "Lampi G, Deidda D, Pinza M, Pompei R. 2001. Enhancement of anti\u2010herpetic activity of glycyrrhizic acid by physiological proteins. Antivir Chem Chemother 12: 125\u2013131.", "ArticleIdList": ["11527044"]}, {"Citation": "Lin JC. 2003. Mechanism of action of glycyrrhizic acid in inhibition of Epstein\u2010Barr virus replication in vitro . Antiviral Res 59: 41\u201347.", "ArticleIdList": ["12834859"]}, {"Citation": "Machida H, Nishitani M, Watanabe Y, Yoshimura Y, Kano F, Sakata S. 1995. Comparison of the selectivity of anti\u2010varicella\u2010zoster virus nucleoside analogues. Microbiol Biol 39: 201\u2013206.", "ArticleIdList": ["7603364"]}, {"Citation": "Miyake K, Tango T, Ota Y et al. 2002. Efficacy of Stronger Neo\u2010Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis. J Gastroenterol Hepatol 17: 1198\u20131204.", "ArticleIdList": ["12453280"]}, {"Citation": "Mori K, Sakai H, Suzuki S et al. 1989. Effects of glycyrrhizin (SNMC: stronger Neo\u2010Minophagen C) in hemophilia patients with HIV infection. Tohoku J Exp Med 158: 25\u201335.", "ArticleIdList": ["2781539"]}, {"Citation": "Numazaki K, Nagata N, Sato T, Chiba S. 1994. Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U937 and MRC\u20105 cells by human cytomegalovirus. J Leukoc Biol 55: 24\u201328.", "ArticleIdList": ["8283138"]}, {"Citation": "Ohtsuki K, Iahida N. 1988. Inhibitory effect of glycyrrhizin on polypeptide phosphorylation by polypeptide\u2010dependent protein kinase (kinase P) in vitro . Biochem Biophys Res Commun 157: 597\u2013604.", "ArticleIdList": ["2849432"]}, {"Citation": "Orient H, Hansen BE, Willems M et al. 2006. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomised phase II trial. J Hepatol 45: 539\u2013546.", "ArticleIdList": ["16905220"]}, {"Citation": "Pompei R, Flore O, Marccialis MA, Pani A, Loddo B. 1979. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 281: 689\u2013690.", "ArticleIdList": ["233133"]}, {"Citation": "Pompei R, Paghi L, Ingianni A, Uccheddu P. 1983. Glycyrrhizic acid inhibits influenza virus growth in embryonated eggs. Microbiologica 6: 247\u2013250.", "ArticleIdList": ["6633273"]}, {"Citation": "Robbers JE, Speedie MK, Tyler VE. 1996. Pharmacognosy and Pharmacobiotechnology. Williams & Wilkins: Baltimore, 55\u201356."}, {"Citation": "Sasaki H, Takei M, Kobayashi M, Pollard RB, Suzuki F. 2002. \u20132003. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV\u2010seropositive patients. Pathobiology 70: 229\u2013236.", "ArticleIdList": ["12679601"]}, {"Citation": "Sato H, Goto W, Yamamura J et al. 1996. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res 30: 171\u2013177.", "ArticleIdList": ["8783808"]}, {"Citation": "Sekizawa T, Yanagi K, Itoyama Y. 2001. Glycyrrhizin increases survival of mice with herpes simplex encephalitis. Acta Virol 45: 51\u201354.", "ArticleIdList": ["11394578"]}, {"Citation": "Shibata S. 2000. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakagaku Zasshi 120: 849\u2013862.", "ArticleIdList": ["11082698"]}, {"Citation": "Shiki Y, Shirai K, Saito Y, Yoshida S, Mori Y, Wakashin M. 1992. Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti\u2010liver cell membrane antibody. J Gastroenterol Hepatol 7: 12\u201316.", "ArticleIdList": ["1543863"]}, {"Citation": "Takahara T, Watanabe A, Shiraki K. 1994. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study. Hepatol Res 21: 601\u2013609.", "ArticleIdList": ["7814808"]}, {"Citation": "Tandon A, Tandon BN, Bhujwala RA. 2001. Treatment of subacute hepatitis with lamivudine and intravenous glycyrrhizin: a pilot study. Hepatol Res 20: 1\u20138.", "ArticleIdList": ["11282481"]}, {"Citation": "Thyagarajan S, Jayaram S, Gopalakrishnan V, Hari R, Jeyakumar P, Sripathi M. 2002. Herbal medicines for liver diseases in India. J Gastroenterol Hepatol 17 (Suppl. 3): S370\u2013S376.", "ArticleIdList": ["12472966"]}, {"Citation": "Tochikura TS, Nakashima H, Yamamoto N. 1989. Antiviral agents with activity against human retroviruses. J Acquir Immune Defic Syndr 2: 441\u2013447.", "ArticleIdList": ["2477523"]}, {"Citation": "Utsonomiya T, Kobayashi M, Pollard RB, Suzuki F. 1997. Glycyrrhizin, an active component of licorice root, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother 41: 551\u2013556.", "ArticleIdList": ["PMC163749", "9055991"]}, {"Citation": "Van Rossum TG, Vulto AG, De Man RA, Brouwer JT, Schalm SW. 1998. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 12: 199\u2013205.", "ArticleIdList": ["9570253"]}, {"Citation": "Van Rossum T, Vulto A, Hop W, Schalm W. 2001. Glycyrrhizin\u2010induced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol 96: 2432\u20132437.", "ArticleIdList": ["11513186"]}, {"Citation": "Wang JY, Guo JS, Li H, Liu SL, Zern MA. 1998. Inhibitory effect of glycyrrhizin on NF\u2010kappaB binding activity in CCl4\u2010 plus ethanol\u2010induced liver cirrhosis in rats. Liver 18: 180\u2013185.", "ArticleIdList": ["9716228"]}, {"Citation": "Wang XQ, Li HY, Liu XY et al. 2006. The anti\u2010respiratory syncytial virus effect of active compound of Glycyrrhiza GD4 in vitro . Zhang Yao Cal 29: 692\u2013694.", "ArticleIdList": ["17059011"]}, {"Citation": "Zhang L, Wang B. 2002. Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo\u2010Minophagen C in Chinese patients with chronic hepatitis B. Hepatol Res 24: 220.", "ArticleIdList": ["12393023"]}]}], "History": [{"Year": "2007", "Month": "9", "Day": "22", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "6", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "9", "Day": "22", "Hour": "9", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17886224", "PMC7167979", "10.1002/ptr.2295"]}}], "PubmedBookArticle": []}